BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12799196)

  • 1. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
    Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
    Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
    Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation.
    Ogawa M; Suzuki J; Hishikari K; Takayama K; Tanaka H; Isobe M
    J Am Coll Cardiol; 2008 May; 51(20):1977-85. PubMed ID: 18482668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
    Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
    Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases 2 and 9 in donor liver, cirrhotic liver, and acute rejection after human liver transplantation.
    Kirimlioglu H; Kirimlioglu V; Yilmaz S
    Transplant Proc; 2008 Dec; 40(10):3574-7. PubMed ID: 19100442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermolysin activates equine lamellar hoof matrix metalloproteinases.
    Mungall BA; Pollitt CC
    J Comp Pathol; 2002 Jan; 126(1):9-16. PubMed ID: 11814317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis.
    Mikami Y; Dobschütz EV; Sommer O; Wellner U; Unno M; Hopt U; Keck T
    Surgery; 2009 Feb; 145(2):147-56. PubMed ID: 19167969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis and matrix metalloproteinases in rat renal allografts.
    Inkinen KA; Soots AP; Krogerus LA; Lautenschlager IT; Ahonen JP
    Transpl Int; 2005 May; 18(5):506-12. PubMed ID: 15819797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
    Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
    Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
    Kuroda T; Yoshida Y; Kamiie J; Kovalenko P; Nameta M; Fujinaka H; Yaoita E; Endo T; Ishizuka S; Nakabayashi K; Yamada A; Nagasawa T; Yamamoto T
    Clin Exp Nephrol; 2004 Sep; 8(3):206-15. PubMed ID: 15480897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
    Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
    Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.